首页 | 本学科首页   官方微博 | 高级检索  
     

miR-203a通过靶向抑制CDK6调控膀胱癌细胞增殖及放射敏感性
引用本文:王磊,乔庆东,黄海航,李浩然,何云峰. miR-203a通过靶向抑制CDK6调控膀胱癌细胞增殖及放射敏感性[J]. 中华放射肿瘤学杂志, 2021, 30(2): 191-197. DOI: 10.3760/cma.j.cn113030-20200623-00319
作者姓名:王磊  乔庆东  黄海航  李浩然  何云峰
作者单位:新乡市中心医院泌尿外一科 453000; 新乡市中心医院放疗科 453000; 新乡医学院基础医学院 453000; 重庆医科大学附属第一医院泌尿外科 400016
基金项目:河南省科技发展计划项目(172102310371);河南省医学科技攻关计划联合共建项目(2018020928)
摘    要:目的:探讨miR-203a在膀胱癌(BC)细胞系(RT-112、T24、5637、UM-UC-3细胞)中的表达及对细胞增殖及放射敏感性的影响。方法:将miR-203a mimics、miR-203a inhibitor、CDK6 siRNA、CDK6表达质粒及相应阴性对照(NC)转染入BC细胞中。实时荧光定量PCR检测...

关 键 词:miR-203a  细胞周期蛋白依赖性激酶  放射敏感性  膀胱癌细胞系
收稿时间:2020-06-23

miR-203a regulates bladder cancer cell proliferation and radiosensitivity by targeting CDK6
Wang Lei,Qiao Qingdong,Huang Haihang,Li Haoran,He Yunfeng. miR-203a regulates bladder cancer cell proliferation and radiosensitivity by targeting CDK6[J]. Chinese Journal of Radiation Oncology, 2021, 30(2): 191-197. DOI: 10.3760/cma.j.cn113030-20200623-00319
Authors:Wang Lei  Qiao Qingdong  Huang Haihang  Li Haoran  He Yunfeng
Affiliation:Department of Urology I, Xinxiang Central Hospital, Xinxiang 453000, China; Department of Radiotherapy, Xinxiang Central Hospital, Xinxiang 453000, China; School of Basic Medicine, Xinxiang Medical College, Xinxiang 453000, China; Department of Urology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Abstract:Objective To investigate the expression of miR-203a in bladder cancer (BC) cell lines (RT-112, T24, 5637, UM-UC-3) and evaluate the effects on BC cell proliferation and radiosensitivity. Methods Mir-203a mimics, mir-203a inhibitor, CDK6siRNA, CDK6 expression plasmid and corresponding negative controls were transfected into BC cells. Quantitative real-time PCR was used to detect the expression of miR-203a in BC cell lines and human bladder epithelial immortalized cell line (SV-HUC-1). CCK8 assay was used to investigate the regulation of miR-203a and cyclin-dependent kinases 6(CDK6) on the proliferation of BC cells. Colony formation assay was performed to assess the effect of miR-203a and CDK6 on the radiosensitivity of BC cells. The target gene of miR-203a was confirmed by luciferase reporter assay. The effect of miR-203a on CDK6 protein expression was detected by Western blot. Multi-group comparison was performed by one-way ANOVA and two-group comparison was conducted by t-test. Results Compared with the SV-HUC-1 cells, the expression levels of miR-203a in RT-112, T24, 5637 and UM-UC-3 cells were significantly down-regulated (all P<0.05). Compared with NC group, overexpression of miR-203a significantly inhibited the proliferation of BC cells, whereas knockdown of miR-203a significantly promoted the proliferation of BC cells (both P<0.05). Compared with NC group, overexpression of miR-203a significantly increased the sensitivity of BC cells to radiotherapy, whereas knockdown of miR-203a significantly weakened the sensitivity of BC cells to radiotherapy (both P<0.05). CDK6 was the target of miR-203a. Compared with NC group, overexpression of miR-203a significantly down-regulated the expression level of CDK6 protein, whereas knockdown of miR-203a significantly up-regulated the expression level of CDK6 protein (both P<0.05). After overexpression of CDK6 in T24 and UM-UC-3 cells transfected with miR-203a mimics, the cell proliferation ability was significantly increased, whereas the sensitivity to radiotherapy was significantly decreased compared with mir-203a mimics (both P<0.05). After CDK6 was silenced in RT-112 and 5637 cells transfected with miR-203a inhibitor, the proliferation ability of cells was significantly decreased, whereas the sensitivity to radiotherapy was remarkably increased compared with miR-203a inhibitor group (both P<0.05). Conclusion miR-203a can serves as a tumor suppressor gene to inhibit the proliferation of BC cells and enhance the radiosensitivity of BC cells.
Keywords:miR-203a  Cyclin-dependent kinases  Radiosensitivity  Bladder cancer cell line  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号